Madeleine L.

Madeleine L. has a diverse work experience in various industries and roles. Madeleine started their career as a Visiting Researcher at SRI International, where they worked on identifying racemization at asparagine residues in Tau protein fragments. Madeleine then joined the University of Texas at San Antonio as a Scientist in the Biomedical Engineering Department, followed by a role as a REU Scientist in the Biophysics Department at the University of Michigan. Madeleine also worked at UTHSCSA as a Scientist in the Biochemistry Department, where they conducted research on macrophages and presented their findings at conferences. Madeleine pursued their Ph.D. at the University of Houston while working as a Ph.D. Candidate. Madeleine then joined Fannin Innovation Studio as a Medical Device BD and later transitioned to the business angel Minority association - baMa, where they served as Chief of Staff and Investor Relations. Madeleine also gained experience in venture capital as a Venture Fellow at GOOSE Capital. Currently, they hold the position of Senior Manager of Business Development and Strategy at Iterion Therapeutics.

Madeleine L. holds a Bachelor of Science degree in Physics/Biophysics from St. Mary's University. Madeleine also obtained a Doctor of Philosophy (Ph.D.) in Biomedical/Medical Engineering from the University of Houston. In addition to their formal education, Madeleine has obtained additional certifications, including "Advanced Competitive Strategy" from Ludwig-Maximilians-Universität München (LMU) through Coursera in April 2020, and "Python for Data Science: Fundamentals" from Dataquest.io in January 2020.